Price $100.18 |
Market Cap
3.98B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
4.0
|
P/B
1.61
|
P/S
1.67
|
Dividend %
-
|
|
P/CF
13.8
|
P/FCF
8.3
|
Op. Cash Flow
721.4K
|
FCF
11.1
|
|
Op. Margin
56.00%
|
Net Margin
43.30%
|
ROE
54.50%
|
ROI
36.80%
|
|
ROA
42.60%
|
EPS Growth
6.10%
|
Current Ratio
4.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | $0.58 | - | - | 22.4M | Strong Buy |
| Endo International PLC (ENDP) | $0.37 | - | - | 124.1M | Strong Buy |
| Psychemedics Corp. (PMD) | $6.29 | - | 4.50% | 35.3M | Strong Buy |
| Cyclo Therapeutics Inc (CYTH) | $2.10 | - | - | 19.4M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.37 | - | - | 212.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
